• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴别疑似脓毒症患者的流感与 COVID-19。

Differentiating influenza from COVID-19 in patients presenting with suspected sepsis.

机构信息

Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.

Department of Infectious Diseases and Immunity, Jessa Hospital, Hasselt, Belgium.

出版信息

Eur J Clin Microbiol Infect Dis. 2021 May;40(5):987-995. doi: 10.1007/s10096-020-04109-x. Epub 2020 Dec 3.

DOI:10.1007/s10096-020-04109-x
PMID:33274416
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7714256/
Abstract

There is a need for a quick assessment of severely ill patients presenting to the hospital. The objectives of this study were to identify clinical, laboratory and imaging parameters that could differentiate between influenza and COVID-19 and to assess the frequency and impact of early bacterial co-infection. A prospective observational cohort study was performed between February 2019 and April 2020. A retrospective cohort was studied early in the COVID-19 pandemic. Patients suspected of sepsis with PCR-confirmed influenza or SARS-CoV-2 were included. A multivariable logistic regression model was built to differentiate COVID-19 from influenza. In total, 103 patients tested positive for influenza and 110 patients for SARS-CoV-2, respectively. Hypertension (OR 6.550), both unilateral (OR 4.764) and bilateral (OR 7.916), chest X-ray abnormalities, lower temperature (OR 0.535), lower absolute leukocyte count (OR 0.857), lower AST levels (OR 0.946), higher LDH (OR 1.008), higher ALT (OR 1.044) and higher ferritin (OR 1.001) were predictive of COVID-19. Early bacterial co-infection was more frequent in patients with influenza (10.7% vs. 2.7%). Empiric antibiotic usage was high (76.7% vs. 84.5%). Several factors determined at presentation to the hospital can differentiate between influenza and COVID-19. In the future, this could help in triage, diagnosis and early management. Clinicaltrial.gov Identifier: NCT03841162.

摘要

需要快速评估因重病而到医院就诊的患者。本研究的目的是确定可区分流感和 COVID-19 的临床、实验室和影像学参数,并评估早期细菌合并感染的频率和影响。进行了一项 2019 年 2 月至 2020 年 4 月之间的前瞻性观察性队列研究。在 COVID-19 大流行早期对回顾性队列进行了研究。纳入了经 PCR 确诊为流感或 SARS-CoV-2 的疑似败血症患者。建立了一个多变量逻辑回归模型,以区分 COVID-19 和流感。共有 103 例患者的流感 PCR 检测结果呈阳性,110 例患者的 SARS-CoV-2 PCR 检测结果呈阳性。高血压(OR6.550)、单侧(OR4.764)和双侧(OR7.916)、胸部 X 线异常、较低的体温(OR0.535)、较低的绝对白细胞计数(OR0.857)、较低的 AST 水平(OR0.946)、较高的 LDH(OR1.008)、较高的 ALT(OR1.044)和较高的铁蛋白(OR1.001)与 COVID-19 相关。流感患者早期细菌合并感染更常见(10.7% vs. 2.7%)。经验性使用抗生素的情况较为普遍(76.7% vs. 84.5%)。在医院就诊时确定的几个因素可以区分流感和 COVID-19。在未来,这可能有助于分诊、诊断和早期管理。Clinicaltrial.gov 标识符:NCT03841162。

相似文献

1
Differentiating influenza from COVID-19 in patients presenting with suspected sepsis.鉴别疑似脓毒症患者的流感与 COVID-19。
Eur J Clin Microbiol Infect Dis. 2021 May;40(5):987-995. doi: 10.1007/s10096-020-04109-x. Epub 2020 Dec 3.
2
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.COVID-19 住院患者的细菌和真菌感染:英国二级保健机构中的回顾性队列研究。
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399. doi: 10.1016/j.cmi.2020.06.025. Epub 2020 Jun 27.
3
Diagnostic yield of bacteriological tests and predictors of severe outcome in adult patients with COVID-19 presenting to the emergency department.在因 COVID-19 而到急诊科就诊的成年患者中,细菌学检测的诊断效果及其导致重症的预测因子。
Emerg Med J. 2021 Sep;38(9):685-691. doi: 10.1136/emermed-2020-211027. Epub 2021 Jul 21.
4
Coinfection With SARS-CoV-2 and Influenza A(H1N1) in a Patient Seen at an Influenza-like Illness Surveillance Site in Egypt: Case Report.埃及流感样疾病监测点发现的 SARS-CoV-2 和甲型 H1N1 流感病毒双重感染病例报告。
JMIR Public Health Surveill. 2021 Apr 28;7(4):e27433. doi: 10.2196/27433.
5
Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization.单核细胞绝对计数作为区分需要住院治疗的患者感染新冠病毒和甲型/乙型流感的初步工具。
Infez Med. 2020 Dec 1;28(4):534-538.
6
Comparison of the clinical characteristics and outcomes of hospitalized adult COVID-19 and influenza patients - a prospective observational study.比较住院成人 COVID-19 和流感患者的临床特征和结局:一项前瞻性观察研究。
Infect Dis (Lond). 2021 Feb;53(2):111-121. doi: 10.1080/23744235.2020.1840623. Epub 2020 Nov 10.
7
Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients.与流感患者相比,COVID-19 患者的继发性细菌感染是死亡的更强预测因素。
Sci Rep. 2021 Jun 16;11(1):12703. doi: 10.1038/s41598-021-92220-0.
8
Differential diagnosis of coronavirus disease 2019 pneumonia or influenza A pneumonia by clinical characteristics and laboratory findings.根据临床特征和实验室检查结果鉴别诊断 2019 年冠状病毒病肺炎或甲型流感肺炎。
J Clin Lab Anal. 2021 Feb;35(2):e23685. doi: 10.1002/jcla.23685. Epub 2021 Feb 12.
9
Comparison of patients hospitalized with COVID-19, H7N9 and H1N1.比较因 COVID-19、H7N9 和 H1N1 住院的患者。
Infect Dis Poverty. 2020 Dec 2;9(1):163. doi: 10.1186/s40249-020-00781-5.
10
Coinfection with SARS-CoV-2 and Influenza A Virus in a 32-Year-Old Man.一名32岁男性感染新型冠状病毒和甲型流感病毒的合并感染病例
Am J Case Rep. 2020 Nov 14;21:e926092. doi: 10.12659/AJCR.926092.

引用本文的文献

1
Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis.COVID-19 患者的抗菌药物耐药性:系统评价和荟萃分析。
Lancet Microbe. 2023 Mar;4(3):e179-e191. doi: 10.1016/S2666-5247(22)00355-X. Epub 2023 Jan 31.
2
Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis.COVID-19 患者的细菌合并感染和抗生素管理:系统评价和荟萃分析。
BMC Infect Dis. 2023 Jan 9;23(1):14. doi: 10.1186/s12879-022-07942-x.
3
A Retrospective, Monocentric Study Comparing Co and Secondary Infections in Critically Ill COVID-19 and Influenza Patients.

本文引用的文献

1
Care for adult non-ICU Covid-19 patients: early experiences from a Belgian tertiary care centre.成人非重症监护病房新冠病毒肺炎患者的护理:比利时一家三级护理中心的早期经验
Neth J Med. 2020 Apr;78(3):111-115.
一项比较重症 COVID-19 患者和流感患者合并感染与继发感染的回顾性单中心研究。
Antibiotics (Basel). 2022 May 24;11(6):704. doi: 10.3390/antibiotics11060704.
4
Comparison of the clinical parameters of patients with COVID-19 and influenza using blood test data: a retrospective cross-sectional survey.利用血液检测数据比较 COVID-19 和流感患者的临床参数:一项回顾性横断面调查。
J Int Med Res. 2022 Feb;50(2):3000605221083751. doi: 10.1177/03000605221083751.
5
Worldwide prevalence of microbial agents' coinfection among COVID-19 patients: A comprehensive updated systematic review and meta-analysis.全球 COVID-19 患者中微生物共感染的流行情况:一项全面更新的系统评价和荟萃分析。
J Clin Lab Anal. 2022 Jan;36(1):e24151. doi: 10.1002/jcla.24151. Epub 2021 Dec 1.
6
Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression.预测 COVID-19 患者呼吸道和血流细菌感染的因素和微生物学研究:快速综述更新和荟萃回归分析。
Clin Microbiol Infect. 2022 Apr;28(4):491-501. doi: 10.1016/j.cmi.2021.11.008. Epub 2021 Nov 26.
7
Bloodstream Infections in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis.新型冠状病毒肺炎住院患者的血流感染:一项系统评价和荟萃分析
Microorganisms. 2021 Sep 23;9(10):2016. doi: 10.3390/microorganisms9102016.
8
Comparison of clinical and biochemical features of hospitalized COVID-19 and influenza pneumonia patients.比较住院 COVID-19 与流感肺炎患者的临床和生化特征。
J Med Virol. 2021 Dec;93(12):6619-6627. doi: 10.1002/jmv.27218. Epub 2021 Jul 29.
9
Bacterial coinfection among coronavirus disease 2019 patient groups: an updated systematic review and meta-analysis.2019冠状病毒病患者群体中的细菌合并感染:一项更新的系统评价与荟萃分析
New Microbes New Infect. 2021 Sep;43:100910. doi: 10.1016/j.nmni.2021.100910. Epub 2021 Jul 1.